concerta extended-release tablet 27 mg
johnson & johnson international (singapore) pte ltd - methylphenidate 23.34mg eqv methylphenidate hcl - tablet, film coated - 27mg - methylphenidate 23.34mg eqv methylphenidate hcl 27mg
concerta extended-release tablet 18 mg
johnson & johnson international (singapore) pte ltd - methylphenidate 15.57mg eqv methylphenidate hcl - tablet, film coated - 18mg - methylphenidate 15.57mg eqv methylphenidate hcl 18mg
concerta extended-release tablet 36 mg
johnson & johnson international (singapore) pte ltd - methylphenidate 31.13mg eqv methylphenidate hcl - tablet, film coated - 36mg - methylphenidate 31.13mg eqv methylphenidate hcl 36mg
concerta extended-release tablet 54 mg
johnson & johnson international (singapore) pte ltd - methylphenidate 46.71mg eqv methylphenidate hcl - tablet, film coated - 54mg - methylphenidate 46.71mg eqv methylphenidate hcl 54mg
ritalin la capsule 20 mg
novartis (singapore) pte ltd - methylphenidate hcl - capsule - 20 mg - methylphenidate hcl 20 mg
ritalin tablet 10 mg
novartis (singapore) pte ltd - methylphenidate hcl - tablet - 10 mg - methylphenidate hcl 10 mg
concerta xl 36 mg prolonged-release tablets
janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 36 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (adhd) in children aged 6 years of age and over when remedial measures alone prove insufficient
concerta xl 18 mg prolonged-release tablets
janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 18 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder (adhd) in children aged 6 years of age and over when remedial measures alone prove insufficient.
concerta xl 54mg prolonged release tablets
janssen-cilag ltd - methylphenidate hydrochloride - prolonged-release tablet - 54 mg - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit hyperactivity disorder in children aged 6 years of age and over when remedial measures alone prove insufficient.
concerta xl 18mg tablets
janssen-cilag ltd - methylphenidate hydrochloride - modified-release tablet - 18mg